The phrase "activated in the peripheral" is correct and usable in written English.
It can be used in contexts related to biology, neuroscience, or technology, particularly when discussing processes or functions that occur in the peripheral nervous system or peripheral devices.
Example: "The sensory receptors were activated in the peripheral, allowing the organism to respond to external stimuli."
Alternatives: "triggered in the periphery" or "stimulated in the peripheral system".
"You don't want T cells activated in the peripheral blood," Hafler says.
Molecular evidence confirms that the apoptotic cascade is activated in the peripheral villi and, over an extended period, this would be sufficient to account for their regression.
If these data are confirmed in larger studies it suggests that leukocytes may be primed and activated in the peripheral circulation at the onset of labour, with subsequent invasion of the myometrium and cervix, thereby potentially initiating and propagating cervical ripening and uterine contractions.
At 4 h, only few SGC were activated in the V1 (anteromedial) region of the ganglion, compared to the peripheral zone (data not shown).
This means that peripheral pain pathways can be activated in the absence of Nav1.7 after nerve damage.
LC3 expression has been seen in surgically resected pancreatic cancer tissue that shows activated autophagy in the peripheral area, which included the invasive border and concomitantly exhibits enhanced expression of carbonic anhydrase [ 62].
As expected, the R26R-EYFP reporter was activated in all peripheral blood leukocytes of pCX-NLS-Cre/R26R-EYFP mice (Figure 3A) and in 85 percent of granulocytes of LysM-Cre/R26R-EYFP mice (Figure 3B).
There is evidence that the coagulation system is activated in patients with peripheral arterial occlusive disease (PAOD).
This suggested that a significant fraction of DNCD3 splenocytes are under a continuous state of activation, which is in line with the hypothesis that DNCD3 cells can be activated in peripheral lymphoid organs [21], [42].
In the present study, we examined whether PARP is activated in peripheral blood mononuclear cells (PBMCs) and lung tissues of human asthmatics and used olaparib AZD-22811), a clinically tested PARP-1 and PARP-2 inhibitor, to conduct a pre-clinical study to determine the efficacy of this drug in blocking established asthma.
